Skip to main content

Radical Nephrectomy for Localized Renal Tumors: Optimum Oncological and Renal Functional Considerations

  • Chapter
  • First Online:
Renal Cell Carcinoma

Part of the book series: Current Clinical Urology ((CCU))

  • 1900 Accesses

Abstract

There will be an estimated 58,240 new cases and 13,040 deaths from kidney cancer in the USA in 2010 [1]. Compared to 1971, this represents a fivefold increase in the incidence and twofold increase in the mortality of renal cancer. Associated risk factors for kidney cancer include hypertension, obesity, and African American race. Epidemiological evidence suggests an increase in all stages of renal cancer, including the advanced and metastatic cases. It is now understood that renal cortical tumors are a family of distinct tumors with variable histology, cytogenetic defects, and metastatic potential [2]. Approximately 90% of the tumors that metastasize are the conventional clear cell carcinoma [3]; however, they account for only 54% of the total number of resected tumors. Approximately 30–40% of renal tumor patients will either present with or later develop metastatic disease. The widespread use of the modern abdominal imaging techniques (CT, MRI, and abdominal ultrasound) over the last two decades, usually ordered to evaluate nonspecific abdominal and musculoskeletal complaints or during unrelated cancer care, has changed the profile of the typical renal tumor patient from one with a massive, symptomatic tumor at presentation to one with a small, asymptomatic, renal mass (<4 cm) incidentally discovered in 70% of the cases [4]. A survival rate of 90% or greater, depending on the tumor histology, is expected for these small tumors if partial (PN) or radical nephrectomy (RN) is performed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics 2010. CA Cancer J Clin. 2010;60(5):277–300.

    Article  PubMed  Google Scholar 

  2. Linehan WM, Walther MM, Zbar B. The genetic basis of cancer of the kidney. J Urol. 2003;170:2163–72.

    Article  PubMed  CAS  Google Scholar 

  3. Kattan MW, Reuter VE, Motzer RJ, Russo P. A postoperative prognostic nomogram for renal cell carcinoma. J Urol. 2001;166:63.

    Article  PubMed  CAS  Google Scholar 

  4. Russo P. Renal cell carcinoma: presentation, staging, and surgical treatment. Semin Oncol. 2000;27:160–76.

    PubMed  CAS  Google Scholar 

  5. Beare JB, McDonald JR. Involvement of renal capsule in surgically removed hypernephroma: gross and histopathological study. J Urol. 1949;61:857–61.

    PubMed  CAS  Google Scholar 

  6. Mortensen H. Transthoracic nephrectomy. J Urol. 1948;60:855.

    PubMed  CAS  Google Scholar 

  7. Robson CJ. Radical nephrectomy for renal cell carcinoma. J Urol. 1963;89:37.

    PubMed  CAS  Google Scholar 

  8. Robson CJ, Churchill BM, Andersen W. The results of radical nephrectomy for renal cell carcinoma. J Urol. 1969;101:297.

    PubMed  CAS  Google Scholar 

  9. Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal cell carcinoma: a clinical and pathological study of 309 cases. Cancer. 1971;28:1165–77.

    Article  PubMed  CAS  Google Scholar 

  10. Patel NP, Lavengood RW. Renal cell carcinoma: natural history and results of treatment. J Urol. 1978;119:722.

    PubMed  CAS  Google Scholar 

  11. Sagalowsky AI, Kadesky KT, Ewalt DM, Kennedy TJ. Factors influencing adrenal metastases in renal cell carcinoma. J Urol. 1994;151:1181–4.

    PubMed  CAS  Google Scholar 

  12. Herrlinger JA, Schrott KM, Schott G, et al. What are the benefits of extended dissection of the regional lymph nodes in the therapy of renal cell carcinoma? J Urol. 1991;146:1224.

    PubMed  CAS  Google Scholar 

  13. Ditonno P, Traficante A, Battaglia M, et al. Role of lymphadenectomy in renal cell carcinoma. Prog Clin Biol Res. 1992;378:169.

    PubMed  CAS  Google Scholar 

  14. Robson CJ. Results of radical thoraco-abdominal nephrectomy in the treatment of renal cell carcinoma. Prog Clin Biol Res. 1982;100:481–8.

    PubMed  CAS  Google Scholar 

  15. Russo P. Open radical nephrectomy for localized renal cell carcinoma. In: Vogelzang NJ, editor. Genitourinary oncology. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 2006. p. 725–31.

    Google Scholar 

  16. Flanigan RC, Salmon SE, Blumenstein BA, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. NEJM. 2001;23:1655–9.

    Article  Google Scholar 

  17. Russo P, O’Brien MF. Surgical intervention in patients with metastatic renal cancer: metastasectomy and cytoreductive nephrectomy. Urol Clin North Am. 2008;35:679–86.

    Article  PubMed  Google Scholar 

  18. Russo P. Multi-modal treatment for metastatic renal cancer – the role of surgery. World J Urol. 2010;28:295–301.

    Article  PubMed  Google Scholar 

  19. Diblasio CJ, Snyder ME, Russo P. Mini flank supra-eleventh incision for open partial or radical nephrectomy. BJU Int. 2006;97(1):149–56.

    Article  PubMed  Google Scholar 

  20. Vasselli JR, Yang JC, Linehan WM, White DE, Rosenberg SA, Walther MM. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma. J Urol. 2001;166:68.

    Article  PubMed  CAS  Google Scholar 

  21. Sorbellini M, Kattan MW, Snyder ME, et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol. 2005;173:48–51.

    Article  PubMed  Google Scholar 

  22. Clayman RV, Kavoussi LR, Soper NJ, et al. Laparoscopic nephrectomy: initial case report. J Urol. 1991;146:278.

    PubMed  CAS  Google Scholar 

  23. Dunn MD, Portis AJ, Shalhav AL, et al. Laparoscopic versus open radical nephrectomy: 9-year experience. J Urol. 2000;164:1153–9.

    Article  PubMed  CAS  Google Scholar 

  24. Chan DY, Cadeddu JA, Jarrett TW, et al. Laparoscopic radical nephrectomy: cancer control for renal cell carcinoma. J Urol. 2001;166:2095–100.

    Article  PubMed  CAS  Google Scholar 

  25. Makhoul B, De La Taille A, Vordos D, et al. Laparoscopic radical nephrectomy for T1 renal cancer: the gold standard? A comparison of laparoscopic vs. open nephrectomy. BJU Int. 2004;93:67–70.

    Article  PubMed  CAS  Google Scholar 

  26. Matin S, Gill I, Worley S, Novick AC. Outcome of laparoscopic radical nephrectomy for sporadic 4 cm or less renal tumor with a normal contra lateral kidney. J Urol. 2002;168:1356–60.

    Article  PubMed  Google Scholar 

  27. Gill IS, Meraney AM, Schweizer DK, et al. Laparoscopic radical nephrectomy in 100 patients. Cancer. 2001;92:1843–55.

    Article  PubMed  CAS  Google Scholar 

  28. Scherr DS, Ng C, Munver R, Sosa ER, Vaughan ED, Del Pizzo J. Practice patterns among urologic surgeons treating localized renal cell carcinoma in the laparoscopic age: technology vs. oncology. Urology. 2003;62:1007–11.

    Article  PubMed  Google Scholar 

  29. Zorn KC, Gong EM, Orvieto MA, et al. Comparison of laparoscopic radical and partial nephrectomy: effects on long-term serum creatinine. Urology. 2007;69:1035–40.

    Article  PubMed  Google Scholar 

  30. Nadler RB, Loeb S, Clemens JQ, et al. A prospective study of laparoscopic radical nephrectomy for T1 tumors – is transperitoneal, retroperitoneal, or hand assisted the best approach? J Urol. 2006;4:1230–3.

    Article  Google Scholar 

  31. Hernandez F, Rha KH, Pinto PA, et al. Laparoscopic nephrectomy: assessment of morcellation versus intact specimen extraction of postoperative status. J Urol. 2003;170:412–5.

    Article  PubMed  Google Scholar 

  32. Viterbo R, Greenberg RE, Al-Saleem T, et al. Prior abdominal surgery and radiation do not complicate the retroperitoneoscopic approach to the kidney or adrenal gland. J Urol. 2005;174:57–60.

    Article  Google Scholar 

  33. Fugita OE, Chan DY, Roberts WW, et al. Laparoscopic radical nephrectomy in obese patients: outcomes and technical considerations. Urology. 2004;63:247–52.

    Article  PubMed  Google Scholar 

  34. Hemal AK, Kumar A. A prospective comparison of laparoscopic and robotic radical nephrectomy for T1-2N0M0 renal cell carcinoma. World J Urol. 2009;27:89–94.

    Article  PubMed  Google Scholar 

  35. Stephanson A, Hakimian A, Snyder ME, Russo P. Complications of radical and partial nephrectomy in a large contemporary cohort. J Urol. 2004;171:130–4.

    Article  Google Scholar 

  36. Soulie M, Seguin P, Richeux L, et al. Urological complications of laparoscopic surgery: experience with 350 procedure at a single center. J Urol. 2000;165:1960.

    Article  Google Scholar 

  37. Vallancien G, Cathelineau X, Baumert H, et al. Complications of transperitoneal laparoscopic surgery in urology. Review of 1311 procedures at a single center. J Urol. 2002;168:23–6.

    Article  PubMed  CAS  Google Scholar 

  38. Wile AH, Roigas J, Degor S, et al. Laparoscopic radical nephrectomy: techniques, results, and oncological outcome in 125 consecutive cases. Eur Urol. 2004;45:483–8.

    Article  Google Scholar 

  39. Meraney AM, Samee AA, Gill IS. Vascular and bowel complications during retroperitoneal laparoscopic surgery. J Urol. 2002;168:1941–4.

    Article  PubMed  Google Scholar 

  40. Kim FJ, Rha KH, Hernandez F, Jarrett TW, Pinto P, Kavoussi L. Laparoscopic radical versus partial nephrectomy: assessment of complications. J Urol. 2003;170:408–11.

    Article  PubMed  Google Scholar 

  41. Simon SD, Castle EP, Ferrigni RG, et al. Complications of laparoscopic nephrectomy: the Mayo Clinic experience. J Urol. 2004;171:1447–50.

    Article  PubMed  Google Scholar 

  42. Segev DL, Muzaale AD, Caffo BS, et al. Perioperative mortality and long-term survival following live kidney donation. JAMA. 2010;503:959–66.

    Article  Google Scholar 

  43. Fehrman-Ekholm I, Duner F, Brink B, et al. No evidence of loss of kidney function in living kidney donors from cross sectional follow up. Transplantation. 2001;72:444–9.

    Article  PubMed  CAS  Google Scholar 

  44. Goldfarb DA, Matin SF, Braun WE, et al. Renal outcome 25 years after donor nephrectomy. J Urol. 2001;166:2043.

    Article  PubMed  CAS  Google Scholar 

  45. Kaplan C, Pasternack B, Shah H, et al. Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol. 1975;80:227.

    PubMed  CAS  Google Scholar 

  46. Bijol V, Mendez GP, Hurwitz S, Rennke HG, Nosé V. Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens. Am J Surg Pathol. 2006;30:575.

    Article  PubMed  Google Scholar 

  47. Lau WK, Blute ML, Weaver AL, et al. Matched comparison of radical nephrectomy vs. nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contra lateral kidney. Mayo Clin Proc. 2000;75:1236–42.

    Article  PubMed  CAS  Google Scholar 

  48. McKiernan J, Simmons R, Katz J, Russo P. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology. 2002;59:816–20.

    Article  PubMed  Google Scholar 

  49. Sarnak M, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for the development of cardiovascular disease: a statement from the American Heart Association Council on kidney in cardiovascular disease. High blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2003;108:2154–69.

    Article  PubMed  Google Scholar 

  50. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on TN prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–72.

    Article  PubMed  CAS  Google Scholar 

  51. Kidney Disease Outcome Quality Imitative. K/DOQI clinical guideline for chronic kidney disease evaluation, classification, stratification. Am J Kidney Dis. 2002;39 Suppl 2:51:5246.

    Google Scholar 

  52. Ritz E, McClellan WW. Overview: increased cardiovascular risk in patients with minor renal dysfunction: an emerging issue with far-reaching consequences. J Am Soc Nephrol. 2004;15:513–6.

    Article  PubMed  Google Scholar 

  53. Shlipak MG, Fried LF, Cushman M, et al. Cardiovascular mortality risk in chronic kidney disease. JAMA. 2005;293:1737–45.

    Article  PubMed  CAS  Google Scholar 

  54. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–47.

    Article  PubMed  CAS  Google Scholar 

  55. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;35:1296–305.

    Article  Google Scholar 

  56. Foley RN, Wang C, Collins AJ. Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES 3 study. Mayo Clin Proc. 2005;80:1270–7.

    Article  PubMed  Google Scholar 

  57. Stevens LA, Coresh J, Green T, Levey AS. Assessing kidney function – measured and estimated glomerular filtration rate. N Engl J Med. 2006;354:2473–83.

    Article  PubMed  CAS  Google Scholar 

  58. Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumors: a retrospective cohort study. Lancet Oncol. 2006;7:735–40.

    Article  PubMed  Google Scholar 

  59. Thompson HR, Boorjian SA, Lohse CM, et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared to partial nephrectomy. J Urol. 2008;179:468–73.

    Article  PubMed  Google Scholar 

  60. Huang WC, Elkin EB, Levey AS, Jang TL, Russo P. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors – is there a difference in mortality and cardiovascular outcomes. J Urol. 2009;181:55–62.

    Article  PubMed  Google Scholar 

  61. Tan HJ, Norton EC, Ye Z, Hafez K, Gore JL, Miller DC. Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. JAMA. 2012;207:1629–35.

    Google Scholar 

  62. Kim SP, Thompson H, Boorjian SA, et al. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol. 2012;188:51–7.

    Article  PubMed  Google Scholar 

  63. Foyil KV, Ames CD, Ferguson GG, et al. Long-term changes in creatinine clearance after laparoscopic renal surgery. J Am Coll Surg. 2008;206:511–5.

    Article  PubMed  Google Scholar 

  64. Van Poppel H, Da Pozzo L, Albrecht W, et al. A prospective, randomized EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2011;59:543–52.

    Article  PubMed  Google Scholar 

  65. Lane BR, Poggio ED, Herts BR, Novick AC, Campbell SC. Renal function assessment in the era of chronic kidney disease: renewed emphasis on renal function centered patient care. J Urol. 2009;182:436–44.

    Google Scholar 

  66. Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009;182:1271–9.

    Article  PubMed  Google Scholar 

  67. Hollenback BK, Tash DA, Miller DC, et al. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology. 2006;67:254–9.

    Article  Google Scholar 

  68. Miller DC, Hollingsworth JM, Hafez KS, et al. Partial nephrectomy for small renal masses. An emerging quality of care concern? J Urol. 2006;175:853–7.

    Article  PubMed  CAS  Google Scholar 

  69. Dulabon LM, Lowrance WT, Russo P, Huang WC. Trends in renal tumor surgery delivery within the United States. Cancer. 2010;116:2316–21.

    PubMed  Google Scholar 

  70. Lowrance WT, Yee DS, Savage C, et al. Complications after radical and partial nephrectomy as a function of age. J Urol. 2010;183:1725–30.

    Article  PubMed  Google Scholar 

  71. Miller DC, Taub DA, Dunn RL, Wei JT, Hollenbeck BK. Laparoscopy for renal cell carcinoma: diffusion versus regionalization? J Urol. 2006;176:1102–6.

    Article  PubMed  Google Scholar 

  72. Nuttail M, Cathcart P, van der Meulen J, et al. A description of radical nephrectomy practice and outcomes in England: 1995–2002. BJU Int. 2005;96:58–61.

    Article  Google Scholar 

  73. Thompson HR, Kaag M, Vickers A, et al. Contemporary use of partial nephrectomy at a tertiary care center in the United States. J Urol. 2009;181:993–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul Russo MD, FACS .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Russo, P. (2013). Radical Nephrectomy for Localized Renal Tumors: Optimum Oncological and Renal Functional Considerations. In: Campbell, S., Rini, B. (eds) Renal Cell Carcinoma. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-062-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-062-5_7

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-061-8

  • Online ISBN: 978-1-62703-062-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics